467
Participants
Start Date
September 30, 2005
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
tigecycline
every 12 hours IV (an initial dose of 100 mg followed by 50 mg every 12 hours)
ceftriaxone sodium + metronidazole
Ceftriaxone sodium 2 g once daily intravenously plus metronidazole 1 g to 2 g daily given in divided doses intravenously. Test article should be administered for a minimum of 4 days and up to 14 days at the discretion of the investigator.
Buffalo
Pittsburgh
Newark
Washington D.C.
Charlottesville
Atlanta
Miami
Mobile
Columbus
Columbus
Toledo
Zanesville
Cleveland
Indianapolis
Indianapolis
Detroit
Grand Rapids
Milwaukee
Madison
Minneapolis
Fargo
Bismarck
Butte
Chicago
St Louis
St Louis
Lincoln
Corsiana
Fort Worth
Houston
Houston
Denver
Denver
Salt Lake City
Los Angeles
Torrance
San Diego
Palm Springs
Laguna Hills
Orange
Honolulu
Hartford
Boston
Springfield
West Roxbury
Laconia
Buenos Aires
Buenos Aires
Buenos Aires
Curitiba
São Paulo
São Paulo
Calgary
Victoria
Ajax
Oshawa
Toronto
Toronto
Chicoutimi
Greenfield Park
Montreal
Rimouski
Trois-Rivières
Santiago
Viña del Mar
Mexico D.F. CP
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY